Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Coba J. van Zanten"'
Autor:
Stephanie van de Wall, Janneke M. Meulenberg, Baukje Nynke Hoogeboom, Jessica Sluis, Coba J. van Zanten, Joke Regts, Marco de Bruyn, Toos Daemen, Fenne L. Komdeur, Jos G. W. Kosterink, Amrita Singh, Ed Schuuring, Jan Wilschut, Derk P. Allersma, Ruben Marra, Annemarie Boerma, Ate G.J. van der Zee, Annelies Jorritsma-Smit, Cesar Oyarce, Hans W. Nijman, N Werner, R. Yigit, S. T. Paijens
Publikováno v:
Mol Ther
Molecular Therapy, 29(2), 611-625. CELL PRESS
Molecular therapy, 29(2), 611-625. Nature Publishing Group
Molecular Therapy
Molecular Therapy, 29(2), 611-625. CELL PRESS
Molecular therapy, 29(2), 611-625. Nature Publishing Group
Molecular Therapy
A first-in-human phase I trial of Vvax001, an alphavirus-based therapeutic cancer vaccine against human papillomavirus (HPV)-induced cancers was performed assessing immunological activity, safety, and tolerability. Vvax001 consists of replication-inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f10409c4d65c0a9e0ce6eaeda670e28
https://hdl.handle.net/11370/5172de71-9650-4d26-b08d-9a20ba7f7564
https://hdl.handle.net/11370/5172de71-9650-4d26-b08d-9a20ba7f7564
Autor:
Coba J. van Zanten, Annelies Jorritsma-Smit, Janneke M. Meulenberg, Jolande Schoemaker, Toos Daemen, Daan J Touw, Hans W. Nijman, Jos G. W. Kosterink, Derk P. Allersma
Publikováno v:
European Journal of Pharmaceutical Sciences, 143:105096. ELSEVIER SCIENCE BV
Therapeutic vaccination is being explored as a treatment strategy for the treatment of patients with primary or metastatic tumours. We developed a vaccine targeted to Human papillomavirus (HPV)-induced tumours based on recombinant Semliki Forest viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf1afcd5e61c497310e977d5d4701d6
https://doi.org/10.1016/j.ejps.2019.105096
https://doi.org/10.1016/j.ejps.2019.105096